icon-folder.gif   Conference Reports for NATAP  
 
  ID Week
Oct 8-12 2014
Philadelphia
Back grey_arrow_rt.gif
 
 
 
HIV-1 Attachment Inhibitor Prodrug BMS-663068 in Antiretroviral-Experienced Subjects: Week 24 Subgroup Analysis
 
 
  Reported by Jules Levin
 
Infectious Disease Week
October 8-12, 2014
Philadelphia, PA
 
C Brinson,1 J Lalezari,2 GH Latiff,3 M Thompson,4 J Echevarrķa,5 S Trevino-Perez,6 D Stock,7 SR Joshi,7 GJ Hanna,8 M Lataillade7 for the AI438011 study team
 
1Central Texas Clinical Research, Austin, TX, USA; 2. Quest Clinical Research, San Francisco, CA, US; 3. Maxwell Clinic, Durban, South Africa; 4. AIDS Research Consortium of Atlanta, Atlanta, USA; 5. Hospital Nacional Cayetano Heredia, Lima, Peru; 6. Mexico Centre for Clinical Research, Mexico City, Mexico; 7. Bristol-Myers Squibb, Wallingford, CT, USA; 8. Bristol-Myers Squibb, Princeton, NJ, USA.

IDSA1.gif

IDSA2.gif

IDSA3.gif

IDSA4.gif

IDSA5.gif

IDSA6.gif

IDSA7.gif

IDSA8.gif

IDSA9.gif

IDSA10.gif

IDSA11.gif

IDSA12.gif

IDSA13.gif

IDSA14.gif

IDSA15.gif

IDSA16.gif

IDSA17.gif